AstraZeneca PLC (LON:0A4J)
London · Delayed Price · Currency is GBP · Price in USD 95.10
0.00 (0.00%)
At close: Jan 8, 2026
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 220.48 billion as of January 9, 2026. Its market cap has increased by 36.64% in one year.
Market Cap
220.48B
Enterprise Value
238.75B
Revenue
43.24B
Ranking
n/a
PE Ratio
31.53
Stock Price
95.10
Market Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 220.48B, an increase of 4,745.22%. That is a compound annual growth rate of 12.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 220.48B | 3.10% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.86B |
| HSBC Holdings | 204.97B |
| Shell | 146.39B |
| Rolls-Royce Holdings | 106.90B |
| Rio Tinto Group | 105.87B |
| Unilever | 101.49B |
| British American Tobacco p.l.c. | 87.11B |
| GSK plc | 75.87B |